Schedule 13G ownership disclosure

INSMED INC

COMMON STOCK · CUSIP: 457669307

Event date: 2025-06-30

Filing-level shares
11,230,934
Percent of class
5.9%
  • T. Rowe Price Associates, Inc.

    Shares: 11,230,934 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-25-000567
Form type
SCHEDULE 13G/A
Filer
INSMED Inc
CIK
CIK 1104506
Filed
Aug 14, 2025
Reporting period
Jun 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub